Somatic POLE proofreading domain mutation, immune response and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Background<br/> Precision cancer medicine depends on defining distinct tumour subgroups using biomarkers that may occur at very modest frequencies. One such subgroup comprises patients with exceptionally mutated (ultramutated) cancers caused by mutations that impair DNA polymerase epsilon (POL...
Հիմնական հեղինակներ: | Domingo, E, Freeman-Mills, L, Rayner, E, Glaire, M, Briggs, S, Koelzer, V, Frangou, E, Dutton, P, Kerr, R, Kerr, D, Tomlinson, I, Church, D, EPICOLON consortium |
---|---|
Ձևաչափ: | Journal article |
Հրապարակվել է: |
Lancet
2016
|
Նմանատիպ նյութեր
-
POLE proofreading domain mutation defines a subset of immunogenic colorectal cancers with excellent prognosis
: Glaire, MA, և այլն
Հրապարակվել է: (2016) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
: Van Gool, I, և այլն
Հրապարակվել է: (2015) -
POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer
: Klenerman, P, և այլն
Հրապարակվել է: (2015) -
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
: Van Gool, I, և այլն
Հրապարակվել է: (2018) -
A panoply of errors: polymerase proofreading domain mutations in cancer
: Rayner, E, և այլն
Հրապարակվել է: (2016)